Miniaturized Robotic-Assisted Surgery for Colon Cancer
Author Information
Author(s): Marks John H., Jobst Michael A., Keller Deborah S., Lagares-Garcia Jorge A., Schoonyoung Henry P., Farritor Shane M., Oleynikov Dmitry
Primary Institution: Lankenau Medical Center and Lankenau Institute for Medical Research, Wynnewood, PA USA
Hypothesis
The study aims to evaluate the outcomes of a novel miniaturized robotic-assisted surgery device (mRASD) in colon cancer patients.
Conclusion
The mRASD system demonstrated technical effectiveness and a good safety profile for colectomy in colon cancer patients.
Supporting Evidence
- Thirty patients underwent colectomy with mRASD, with 17 diagnosed with malignancy.
- At 30 days postoperatively, the major complication rate was 6%.
- At one-year follow-up, the overall survival rate was 100% and disease-free survival rate was 94%.
Takeaway
Doctors used a new small robot to help with colon cancer surgery, and it worked well without major problems.
Methodology
A prospective, multicenter, investigational device exemption clinical trial was conducted to evaluate the safety and effectiveness of the mRASD system in colectomy procedures.
Potential Biases
Potential conflicts of interest due to funding and involvement of the device manufacturer in the study.
Limitations
The study had a small number of patients and long-term outcomes were not primary endpoints in the initial IDE clinical study.
Participant Demographics
The mean age of participants was 59.9 years, with 59% male and 76% having a known diagnosis of colon cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website